KEGG   DRUG: Hyaluronate sodium
Entry
D03354                      Drug                                   

Name
Hyaluronate sodium (USAN);
Purified sodium hyaluronate (JP17);
Sodium hyaluronate (JAN);
Legend (TN)
Formula
(C14H20NO11. Na)n
Remark
Therapeutic category: 1319 3999
ATC code: D03AX05 M09AX01 R01AX09 S01KA01
Chemical structure group: DG00380
Product (DG00380): D08043<US> D03354<JP>
Product (mixture): D07632<JP>
Efficacy
Joint function improving agent, Keratoconjunctival protection, Ophthalmic surgery adjunct
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 D DERMATOLOGICALS
  D03 PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS
   D03A CICATRIZANTS
    D03AX Other cicatrizants
     D03AX05 Hyaluronic acid
      D03354  Hyaluronate sodium (USAN) <JP>
 M MUSCULO-SKELETAL SYSTEM
  M09 OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM
   M09A OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM
    M09AX Other drugs for disorders of the musculo-skeletal system
     M09AX01 Hyaluronic acid
      D03354  Hyaluronate sodium (USAN) <JP>
 R RESPIRATORY SYSTEM
  R01 NASAL PREPARATIONS
   R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE
    R01AX Other nasal preparations
     R01AX09 Hyaluronic acid
      D03354  Hyaluronate sodium (USAN) <JP>
 S SENSORY ORGANS
  S01 OPHTHALMOLOGICALS
   S01K SURGICAL AIDS
    S01KA Viscoelastic substances
     S01KA01 Hyaluronic acid
      D03354  Hyaluronate sodium (USAN) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
 1  Agents affecting nervous system and sensory organs
  13  Agents affecting sensory organs
   131  Ophthalmic agents
    1319  Others
     D03354  Hyaluronate sodium (USAN); Purified sodium hyaluronate (JP17); Sodium hyaluronate (JAN)
 3  Agents affecting metabolism
  39  Other agents affecting metabolism
   399  Miscellaneous
    3999  Others
     D03354  Hyaluronate sodium (USAN); Purified sodium hyaluronate (JP17); Sodium hyaluronate (JAN)
Risk category of Japanese OTC drugs [BR:br08312]
 Drugs requiring guidance
  New approved switch OTC drugs
   Purified sodium hyaluronate
    D03354  Hyaluronate sodium (USAN)
 Third-class OTC drugs
  Inorganic and organic chemicals
   Hyaluronic acid
    D03354  Hyaluronate sodium (USAN)
Pharmaceutical additives in Japan [BR:br08316]
 Wetting agent
  D03354  [108952] Sodium hyaluronate
 Tenacious agent
  D03354  [108952] Sodium hyaluronate
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
 Chemicals
  D03354  Purified sodium hyaluronate
  D03354  Purified sodium hyaluronate injection
  D03354  Purified sodium hyaluronate ophthalmic solution
Animal drugs in Japan [BR:br08331]
 96  Agents affecting metabolism
  969  Other agents affecting metabolism
   9699  Agents affecting metabolism, n.e.c.
    D03354  Sodium hyaluronate
Rx-to-OTC switch list in Japan [br08314.html]
 D03354
Other DBs
CAS: 9067-32-7
PubChem: 17397503
NIKKAJI: J209.199B
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system